Serum metabolomics analysis revealed metabolic disorders in Parkinson’s disease

Parkinson’s disease (PD) is by now the second of the most prevalent neurodegenerative diseases in the world, and its incidence is increasing rapidly as the global population ages, with 14.2 million PD patients expected worldwide by 2040. METHODS: We gathered a completion of 45 serum samples, includi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Tian-Tian, Chang, Le, Hou, Li-Wei, Wang, Zhen-Zhen, Li, Dong-Chu, Ren, Zi-Han, Gu, Tao, Wang, Jian-Wen, Chen, Gui-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
5300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256383/
https://www.ncbi.nlm.nih.gov/pubmed/37335671
http://dx.doi.org/10.1097/MD.0000000000033715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256383/
https://www.ncbi.nlm.nih.gov/pubmed/37335671
http://dx.doi.org/10.1097/MD.0000000000033715

Ejemplares similares